NEW YORK ( TheStreet) -- Meridian Bioscience (Nasdaq: VIVO) hit a new 52-week high Thursday as it is currently trading at $25.54, above its previous 52-week high of $25.06 with 18,819 shares traded as of 9:32 a.m. ET. Average volume has been 176,700 shares over the past 30 days. Meridian Bioscience has a market cap of $1 billion and is part of the health care sector and drugs industry. Shares are up 6.8% year to date as of the close of trading on Wednesday. Meridian Bioscience, Inc. operates as an integrated life science company. The company primarily engages in the development, manufacture, sale, and distribution of diagnostic test kits primarily for respiratory, gastrointestinal, viral, and parasitic infectious diseases. The company has a P/E ratio of 40.4, above the average drugs industry P/E ratio of 39.8 and above the S&P 500 P/E ratio of 17.7.
- Practice your VIVO trading strategies and win cash in our stock game.